Cargando…

Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients

BACKGROUND: Autologous hematopoietic stem cell transplantation (AHSCT) treats patients with severe and progressive systemic sclerosis (SSc). However, basic mechanisms associated with the therapeutic efficacy of the procedure are not entirely understood. We aimed to evaluate how AHSCT affects skin fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanin-Silva, Djúlio C., Santana-Gonçalves, Maynara, Kawashima-Vasconcelos, Marianna Y., Lima-Júnior, João R., Dias, Juliana B. E., Moraes, Daniela A., Covas, Dimas T., Malmegrim, Kelen C. R., Ramalho, Leandra, Oliveira, Maria Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052524/ https://www.ncbi.nlm.nih.gov/pubmed/35488348 http://dx.doi.org/10.1186/s13075-022-02779-w

Ejemplares similares

Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy
por: Santana-Gonçalves, Maynara, et al.
Publicado: (2022)

Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
por: Kawashima-Vasconcelos, Marianna Y., et al.
Publicado: (2022)

Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies
por: Zanin-Silva, Djúlio César, et al.
Publicado: (2021)

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy
por: Penaforte-Saboia, Jaquellyne G., et al.
Publicado: (2017)

Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II
por: Malmegrim, K. C. R., et al.
Publicado: (2022)

Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha, Nádia de Cássia, et al.
Publicado: (2019)

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha NC, Nádia de Cássia, et al.
Publicado: (2019)

Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
por: Rocha, José Lucas Martins, et al.
Publicado: (2020)

Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2015)

New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement
por: Couri, Carlos E. B., et al.
Publicado: (2018)

Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
por: de Azevedo, Júlia Teixeira Cottas, et al.
Publicado: (2021)

Genes related to antiviral activity are differentially expressed in CD4(+) T cell in HAM/TSP patients
por: Pinto, Mariana T, et al.
Publicado: (2014)

CD3e expression in HTLV-1-infected individuals is associated with proviral load and Tax expression
por: Pinto, Mariana Tomazini, et al.
Publicado: (2011)

Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients
por: de Lima, Kalil A., et al.
Publicado: (2016)

Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling
por: Saldanha-Araujo, Felipe, et al.
Publicado: (2012)

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2016)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

Autologous hematopoietic transplantation following COVID‐19 infection
por: Brzycki, Marthilde, et al.
Publicado: (2021)

Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation
por: Colunga-Pedraza, Perla R., et al.
Publicado: (2023)

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2021)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

Generation of hematopoietic stem/progenitor cells with sickle cell mutation from induced pluripotent stem cell in serum-free system
por: Paes, Bárbara C.M.F., et al.
Publicado: (2021)

A Methodology for the Development of RESTful Semantic Web Services for Gene Expression Analysis
por: Guardia, Gabriela D. A., et al.
Publicado: (2015)

Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
por: Picanço-Castro, Virgínia, et al.
Publicado: (2020)

Perforin and hematological cancer
por: Covas, Dimas Tadeu
Publicado: (2011)

Accreditation program for blood banking and cell therapy services – a defining moment in the expansion and qualification of Brazilian services
por: Covas, Dimas Tadeu
Publicado: (2014)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

SAT-179 Increased Telomere Length in Adrenocortical Tumors Is Associated with Abnormal Expression of Chromatin Remodelling Factors
por: Stecchini, Monica F, et al.
Publicado: (2020)

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
por: Silvestre, Renata Nacasaki, et al.
Publicado: (2023)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
por: Grubovic, Rada M., et al.
Publicado: (2017)

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN
por: Danner-Koptik, Karina E, et al.
Publicado: (2012)

After the pandemic: the role of science in the future of the countries
por: Palacios, Ricardo, et al.
Publicado: (2020)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tuchman, S. A., et al.
Publicado: (2012)

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma
por: Cox, J E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_90mkj9pdc8p9mnh9qcl2ls4ljl